Navigation Links
SNPs associated with breast cancer risk alter binding affinity for pioneer factor FOXA1
Date:1/23/2013

(Lebanon, NH) Dartmouth scientists showed that more than half of all the SNPs associated with breast cancer risk are located in distant regions and bound by FOXA1, a protein required for estrogen receptor-α (ER) function according to a paper published in the journal Nature Genetics in November.

Jason Moore, PhD, a Third Century Professor of genetics, director of the Institute for Quantitative Biomedical Sciences, and associate director for bioinformatics at Dartmouth-Hitchcock Norris Cotton Cancer Center, and other researchers used a new methodology that combines cistromics, epigenomics, and genotype imputation to annotate the non-coding regions of the geneomie in breast cancer cells and systematically identify the function nature of SNPS associated with breast cancer risk.

"Understanding the biology behind the genetic risk factors opens the door to identifying new drug targets," said Dr. Moore. Results showed that, for breast cancer, the majority of risk-associated SNPs modulate FOXA1 binding. First, they are in complete linkage disequilibrium (LD) with SNPs localized to sites of FOXA1 binding, and, second, these linked SNPs are capable of changing the recruitment of FOXA1 in a significant manner.

Pioneer factors, such as FOXA1, and lineage-specific factors, such as ESR1, underlie the transcriptional programs that establish cell identity. Accordingly, researchers indicated that the majority of SNPs that can disrupt normal breast cell identity modulate the binding of the FOXA1 pioneer factor.

The mechanisms underlying breast cancer riskassociated SNPs are unknown. As with most other complex traits, these risk-associated SNPs map to the non-coding regions of the genome. Researchers demonstrated that breast cancerassociated SNPs are enriched for FOXA1 and ESR1 transcription factorbinding sites and H3K4me1 histone modification. Enrichment is dependent on factor, cell type and cancer type. The body of evidence supporting regulatory mechanisms for GWAS-identified risk-associated SNPs is steadily growing. Heterozygous sites with differential allelic occupancy within 100 bp of transcription start sites have been shown to have a strong association with differential gene expression and to be enriched for GWAS-identified SNPs31. Binding of the FOXA1 pioneer factor is central for chromatin opening and nucleosome positioning favorable to transcription factor recruitment. In addition, FOXA1 is central to the establishment of the transcriptional programs that respond to estrogen stimulation in ESR1-positive breast cancer cells.


'/>"/>

Contact: Donna M. Dubuc
donna.m.dubuc@hitchcock.org
603-653-3615
Dartmouth-Hitchcock Medical Center
Source:Eurekalert

Related medicine news :

1. Low birth weight not associated with asthma risk
2. Parasitic worms may help treat diseases associated with obesity
3. HPV-associated cancer incidence rates point to needed efforts to increase HPV vaccination coverage
4. Researchers zero in on cognitive difficulties associated with menopause
5. Higher levels of obesity associated with increased risk of death
6. Late-life depression associated with prevalent mild cognitive impairment, increased risk of dementia
7. Elevated levels of C-reactive protein appear associated with psychological distress, depression
8. Study: Blood transfusion associated with increased risk of death for patients with heart attack
9. Scripps Florida scientists create new approach to destroy disease-associated RNAs in cells
10. Low adiponcetin associated with increased pancreatic cancer risk
11. Team solves mystery associated with DNA repair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, 2016 ... mobile pulmonary function testing company, is now able to perform sophisticated ... by ndd Medical Technologies , Inc. Patients ... hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients ... get any needed testing done in the comfort of her own ...
Breaking Medicine Technology: